Skip to main content

Regulatory and Washington

  • Atico recalls holiday rattle baby slippers

    WASHINGTON — Atico International USA issued a voluntary recall of 57,000 holiday rattle baby slippers amid a choking hazard, according to the Consumer Product Safety Commission.

    The CPSC reported that the soft shoes with built-in rattles were imported from China by Atico International USA of Fort Lauderdale, Fla., and sold nationwide at Walgreens stores from October 2010 through January 2011 for about $5.

  • FDA attacks ‘lose pounds quick’ weight-loss frauds

    SILVER SPRING, Md. — The Food and Drug Administration on Tuesday outlined a new campaign attacking fraudulent weight-loss products marketed as dietary supplements, especially those companies that proffer a “magic pill” that almost immediately achieves weight loss.

  • NACDS announces guest speakers for annual meeting

    ALEXANDRIA, Va. — This year's National Association of Chain Drug Stores Annual Meeting will feature a lineup of speakers ranging from political leaders and policy experts to best-selling authors and culinary connoisseurs. This year's meeting will run from April 30 to May 3 in Scottsdale, Ariz.

  • New legislation looks to cut out 'use-it-or-lose-it' provision from FSAs

    WASHINGTON — Reps. Charles Boustany, R-La., and John Larson, D-Conn., on Friday introduced bipartisan legislation that would eliminate the “use-it-or-lose-it” provision associated with flexible spending accounts.

  • NCPA responds to congressional members' concerns over short-term cycle dispensing rule

    ALEXANDRIA, Va. — Ten members of Congress expressed concerns over a provision in the Patient Protection and Affordable Care Act that is said to reduce Medicare program costs, according to the Centers for Medicare and Medicaid Services.

  • '60 Minutes' examines counterfeit drug problem

    NEW YORK — "Fake drugs are a big threat and an exploding threat," Kumar Kibble, deputy director of Immigration and Customs Enforcement, told the news program "60 Minutes" in a segment that appeared Sunday night.

  • McNeil signs consent decree regarding manufacturing facilities

    FORT WASHINGTON, Pa. — McNeil last week finalized the terms of a consent decree of permanent injunction with the Food and Drug Administration for manufacturing facilities operated by the McNeil Consumer Healthcare Division in Las Piedras, Puerto Rico; Fort Washington, Pa.; and Lancaster, Pa.

    The consent decree is subject to approval by the U.S. District Court for the Eastern District of Pennsylvania.

  • CHPA taps Paul Sturman as new board chairman

    WASHINGTON — Members of the Consumer Healthcare Products Association last week elected Paul Sturman, president and general manager of Pfizer Consumer Healthcare, to chair the association’s board, the association announced Monday.

X
This ad will auto-close in 10 seconds